Access granted: CMS greenlights more than 150 participants for chronic care experiment
This image was generated by AI and may not depict real events.
The Center for Medicare and Medicaid Innovation has provisionally approved over 150 companies and providers to participate in an experimental Medicare program for technology-supported chronic care. The program, called ACCESS, will pay participants set rates to treat chronic conditions based on measurable health outcomes.
The Center for Medicare and Medicaid Innovation has approved over 150 companies to participate in an experimental Medicare program. The program, ACCESS, will pay set rates to treat chronic conditions like diabetes and hypertension. Participants include mental health apps and wearable device makers. The program is an alternative to paying for individual technology services. Most participants had not previously served Medicare patients. The large number of applications exceeded expectations.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.